Revenue climbed 22% (GAAP) for the three months ended June 30, 2025, compared to the prior year period, largely due to international growth in the Vycor Medical division. Non-GAAP operating profit ...

Eli Lilly's stock dipped after drug trial results, but strong Q2 2025 earnings and market position make it a strong buy. Read ...

Key Points GAAP revenue reached $2.44 billion in Q2 2025, rising 13.1% year over year (GAAP). Gross and operating margins declined significantly (GAAP), with gross margin down 1.6 percentage points.

WM Technology, Inc. (NASDAQ: MAPS) Q2 2025 Earnings Call Transcript August 7, 2025 WM Technology, Inc. misses on earnings ...

MercadoLibre's strong Q2, GOOG ad partnership, and fintech growth reinforce its Latam dominance despite FX risks. Find out ...

Year-to-date Net Income has exceeded Adjusted Net Income by $4.1 million, as discrete items have lowered the effective tax ...

GigaCloud Technology Inc. (NASDAQ: GCT) Q2 2025 Earnings Call Transcript August 7, 2025 GigaCloud Technology Inc. beats ...

Please note that the limited information that follows in this press release is a summary and is not adequate for making an informed investment decision.

Please note that the limited information that follows in this press release is not adequate to make an informed investment judgment.

2025 Non-GAAP Guidance: Initiated 2025 non-GAAP guidance at $3.53–$3.65 per share, contingent upon the outcome of the Montana ...